| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Arch Therapeutics Inc (OTCQB: ARTH)
ARTH Technical Analysis
5
| As on 9th Jun 2023 ARTH STOCK Price closed @ 3.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.07 & Strong Buy for SHORT-TERM with Stoploss of 0.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ARTHSTOCK Price
| Open | 3.15 | Change | Price | % |
| High | 3.15 | 1 Day | -0.10 | -3.08 |
| Low | 3.15 | 1 Week | 0.05 | 1.61 |
| Close | 3.15 | 1 Month | 0.15 | 5.00 |
| Volume | 200 | 1 Year | 3.06 | 3400.00 |
| 52 Week High 7.00 | 52 Week Low 0.02 | ||||
OTCQB USA Most Active Stocks
| BMIX | 0.01 | % |
| MOBQ | 0.18 | -5.26% |
| FNMA | 0.45 | 0.00% |
| ALPP | 3.56 | -0.80% |
| ALPP | 3.56 | -0.80% |
| SHMP | 0.06 | 0.00% |
| NWBO | 0.73 | 0.00% |
| VPLM | 0.08 | % |
| NLST | 3.72 | -8.60% |
| SRNA | 2.78 | 14.88% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| ARTH Daily Charts |
ARTH Intraday Charts |
Whats New @ Bazaartrend |
ARTH Free Analysis |
|
|
ARTH Important Levels Intraday
| RESISTANCE | 3.15 |
| RESISTANCE | 3.15 |
| RESISTANCE | 3.15 |
| RESISTANCE | 3.15 |
| RESISTANCE | 3.15 |
| RESISTANCE | 3.15 |
| RESISTANCE | 3.15 |
| RESISTANCE | 3.15 |
ARTH Forecast April 2024
| 4th UP Forecast | 3.23 |
| 3rd UP Forecast | 3.2 |
| 2nd UP Forecast | 3.19 |
| 1st UP Forecast | 3.17 |
| 1st DOWN Forecast | 3.13 |
| 2nd DOWN Forecast | 3.11 |
| 3rd DOWN Forecast | 3.1 |
| 4th DOWN Forecast | 3.07 |
ARTH Weekly Forecast
| 4th UP Forecast | 3.25 |
| 3rd UP Forecast | 3.22 |
| 2nd UP Forecast | 3.20 |
| 1st UP Forecast | 3.18 |
| 1st DOWN Forecast | 3.12 |
| 2nd DOWN Forecast | 3.10 |
| 3rd DOWN Forecast | 3.08 |
| 4th DOWN Forecast | 3.05 |
ARTH Forecast2024
| 4th UP Forecast | 16.62 |
| 3rd UP Forecast | 12.3 |
| 2nd UP Forecast | 9.63 |
| 1st UP Forecast | 6.96 |
| 1st DOWN Forecast | -0.66 |
| 2nd DOWN Forecast | -3.33 |
| 3rd DOWN Forecast | -6 |
| 4th DOWN Forecast | -10.32 |
Arch Therapeutics Inc ( OTCQB USA Symbol : ARTH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ARTH Business Profile
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts. Address: 235 Walnut Street, Framingham, MA, United States, 01702
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service